# FDA Inspection 1174389 - Oxford Pharmaceuticals, LLC - June 08, 2022

Source: https://www.keypedia.com/records/fda_inspections/oxford-pharmaceuticals-llc/5e6eb0a6-2d06-4954-8adf-d9a10dd56b80
Source feed: FDA_Inspections

> FDA Inspection 1174389 for Oxford Pharmaceuticals, LLC on June 08, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1174389
- Company Name: Oxford Pharmaceuticals, LLC
- Inspection Date: 2022-06-08
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1221787 - 2023-11-03](https://www.keypedia.com/records/fda_inspections/oxford-pharmaceuticals-llc/0e32951c-75a0-4d53-b01e-ec21522685b5)
- [FDA Inspection 1092451 - 2019-05-22](https://www.keypedia.com/records/fda_inspections/oxford-pharmaceuticals-llc/820c91ad-1442-4bd2-96b0-84faa633141e)

Company: https://www.keypedia.com/companies/oxford-pharmaceuticals-llc/5294310a-05a2-4599-bf9e-720929f040ee

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c